| Biomarker ID | 1680 |
| PMID | 25847734 |
| Year | 2015 |
| Biomarker | %p2PSA |
| Biomarker Basis | Concentration Based |
| Biomolecule | Protein |
| Source | Serum |
| Subjects | Humans |
| Regulation | NA |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | NA |
| Experiment | High Grade PCa Vs Low Grade PCa |
| Type of Biomarker | Prognostic |
| Cohort | 250 patients, 112 with Prostate cancer and 138 with No prostate cancer were selected for analysis. Out of 112, 77 patients had high grade PCa and 35 had low grade PCa |
| Senstivity | NA |
| Specificity | NA |
| AUC | 0.724 (95% CI: 0.654-0.795) |
| Accuracy | NA |
| Level Of Significance | NA |
| Method Used | Immunoassays |
| Clinical | No |
| Remarks | Low grade PCa was defined as Gleason 6 and high grade PCa as ≥Gleason 7. |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | NA |